Abbvie

LUPRON DEPOT

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / LUPRON DEPOT – J1950

Manufacturer:

Abbvie

Name:

LUPRON DEPOT

HCPCS Code Descriptor:

Injection, leuprolide acetate (for depot suspension), per 3.75 mg

Category:

J Code

HCPCS:

J1950

NDC(s):

00074-2282-03, 00074-3641-03, 00074-3663-03, 00074-3779-03, 00074-9694-03, 00074-2440-03, 00074-2108-03

Primary Type:

Growth Disorder

Generic/Specialty Status:

LEUPROLIDE DEPOT 505(b)(2) Pathway

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

LUPRON DEPOT is a Growth Disorder drug manufactured by Abbvie and administered via the Intramuscular route of administration. The J Code: J1950 is aligned to the drug LUPRON DEPOT.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/86

HCPCS Effective Date:

1/1/97

HCPCS Short Description:

Leuprolide acetate /3.75 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.abbvie.com/content/dam/abbvie-com2/pdfs/pap/lupron-application.pdf

LUPRON DEPOT - J1950